Construction and Validation of an In-hospital Mortality Risk Prediction Model for Acute Ischemic Stroke Patients
Firstly, the application effect of the existing predictive models, SOAR and GWTG-Stroke, was verified in Guangdong acute ischemic Stroke population, and the clinical application effect of the existing predictive models was verified.
Secondly, the predictive value of clinical indicators was analyzed, SOAR and GWTG-Stroke scores were optimized, and an improved prediction Model (New Model) was constructed.
The third is to apply the New Model to clinical practice, collect clinical data and evaluate the prediction effect of the Model, and evaluate the prediction efficiency of the improved prediction Model.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
This research is mainly divided into two parts. The first part is to verify and optimize the existing prediction model. Through continuous collection of clinical data of acute ischemic Stroke patients hospitalized in Shenzhen Second People's Hospital from January 2017 to December 2021, including baseline indicators and end point events, based on the existing prediction model (SOAR, GWTG-Stroke), The predictive probability was calculated and compared with the actual mortality during hospitalization. The ROC curve, calibration curve and decision curve were used to evaluate the model's differentiation, calibration and clinical application value.
Using retrospective data, multivariate logistic regression was used to analyze the predictive value of baseline clinical indicators, screen risk factors, and optimize the prediction model of SOAR and GWTG-Stroke.
Extreme Gradient Boosting (XGBOOST) was used to select variables, and logistic regression model was used based on Akaike Information Criterion.
AIC) was used to construct an improved mortality risk prediction Model (New Model). Decision curves were used to compare the models. Combined with the clinical significance of the indicators, the construction of the prediction Model was improved.
The model was validated internally by resampling with computer simulation. The second part is to evaluate the clinical application effect of the improved prediction Model. The clinical data of acute ischemic stroke patients hospitalized in Shenzhen Second People's Hospital and Shenzhen Longhua District People's Hospital from January 2022 to December 2023 are collected continuously. The New Model is applied in the clinic, and the New Model is validated in the external time and space.
Evaluate prediction effectiveness and extrapolation.
Tipo di studio
Iscrizione (Anticipato)
Contatti e Sedi
Contatto studio
- Nome: Gao Yan, Ph.D
- Numero di telefono: 13660367430
- Email: gaoyanluoyang163@.com
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- ≥18 years old;
- It meets the diagnostic criteria of China Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018, and bleeding is confirmed by head MRI or excluded by CT after admission;
- Admission within 72 hours of onset. -
Exclusion Criteria:
- Non-vascular causes and transient ischemic attack;
- with severe hepatic and renal dysfunction;
- Central nervous system infection, recent history of severe trauma, and malignant tumors affecting survival time;
- Incomplete main clinical data. -
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
In-hospital mortality
Lasso di tempo: 7-day in-hospital mortality rates
|
Deaths during hospitalization in patients with acute ischemic stroke
|
7-day in-hospital mortality rates
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Anticipato)
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 20213357006
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Ictus ischemico acuto
-
Yonsei UniversityReclutamentoIschemic Heart Disease | Cardiopatia Non IschemicaCorea del Sud
-
People's Hospital of Guangxi Zhuang Autonomous...CompletatoLesioni polmonari acute (ALI)Cina
-
Fenerbahce UniversityIscrizione su invitoUstioni acuteTurchia (Türkiye)
-
BioMérieuxReclutamentoInfezioni respiratorie acute (ARI)Stati Uniti
-
Lumos DiagnosticsReclutamento
-
Tam Anh Research InstituteReclutamentoInfezioni respiratorie acute (ARI)Vietnam
-
Lohmann & RauscherReclutamentoFerite acute e cronicheGermania
-
MMSx Authority Institute for Movement Mechanics...CompletatoDolore muscoloscheletrico - Condizioni acute e subacuteStati Uniti, India
-
Aswan UniversityIscrizione su invitoDiagnosi precoce di lesioni renali acuteEgitto
-
Antoni RibasNon ancora reclutamentoLa guarigione delle ferite | Ferite Cutanee AcuteStati Uniti